Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-07-24 00:00:00 ET · period of report 2024-07-22 · accession 0001140361-24-034029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-24 | 2024-07-22 | RCKT | Militello John | See Remarks | S - Sale | $23.02 | -812 | 52.5K | -2% | -$18.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-22 | S | D | 812 | $23.02 | 52,515 | D | — | — | (F1) The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. |